Journal of the American College of Surgeons
Volume 205, Issue 4 , Pages 546-557 , October 2007

Selective Administration of Prophylactic Octreotide During Pancreaticoduodenectomy: A Clinical and Cost-Benefit Analysis in Low- and High-Risk Glands

Abstract presented at the American College of Surgeons 92nd Annual Clinical Congress, Surgical Forum, Chicago, IL, October 2006.

Received 15 February 2007 ,Accepted 9 May 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Competing Interests Declared: None.

 This research was conducted with support from the Clinical Research Fellowship Program at Harvard Medical School offered by the Doris Duke Charitable Foundation and the Harvard PASTEUR Program and Office of Enrichment Programs.

PII: S1072-7515(07)00629-1

doi: 10.1016/j.jamcollsurg.2007.05.011

Journal of the American College of Surgeons
Volume 205, Issue 4 , Pages 546-557 , October 2007

Article Tools

* Image Usage & Resolution